Liquidia Corporation Common Stock (LQDA) is a publicly traded Healthcare sector company. As of September 30, 2026, LQDA trades at $70.50 with a market cap of $6.59B and a P/E ratio of 44.81. LQDA moved -0.27% today. Year to date, LQDA is +104.96%; over the trailing twelve months it is +210.04%. Its 52-week range spans $11.26 to $93.61. Analyst consensus is buy with an average price target of $106.71. Rallies surfaces LQDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Liquidia Corporation Common Stock (LQDA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LQDA moved -0.27% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $70.50 |
| Market Cap | $6.59B |
| P/E Ratio | 44.81 |
| EPS | $1.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $93.61 |
| 52-Week Low | $11.26 |
| Volume | 664 |
| Avg Volume | 0 |
| Revenue (TTM) | $450.91M |
| Net Income | $138.61M |
| Gross Margin | 0.00% |
7 analysts cover LQDA: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $106.71.